Authors:
Sasaki, K
Akibayashi, S
Yazawa, N
Doan, QT
Ali, SMF
Citation: K. Sasaki et al., Experimental modeling of the SAGD process - Enhancing SAGD performance with periodic stimulation of the horizontal producer, SPE J, 6(1), 2001, pp. 89-97
Authors:
Honami, Y
Arihara, N
Sato, K
Takeda, H
Yazawa, N
Citation: Y. Honami et al., Effective phase equilibrium calculation for equation of state compositional reservoir simulation, SEKIYU GAKK, 44(4), 2001, pp. 244-251
Authors:
Sasaki, K
Akibayashi, S
Yazawa, N
Doan, Q
Ali, SMF
Citation: K. Sasaki et al., Numerical and experimental modelling of the steam assisted gravity drainage (SAGD) process, J CAN PET T, 40(1), 2001, pp. 44-50
Authors:
Yazawa, N
Ihn, H
Yamane, K
Kubo, M
Fujimoto, M
Kikuchi, K
Soma, Y
Tamaki, K
Citation: N. Yazawa et al., Elevated circulating soluble CD30 levels in patients with polymyositis/dermatomyositis, BR J DERM, 145(4), 2001, pp. 676-678
Authors:
Asano, Y
Ihn, H
Yamane, K
Yazawa, N
Kubo, M
Fujimoto, M
Tamaki, K
Citation: Y. Asano et al., Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis, ARTH RHEUM, 44(6), 2001, pp. 1363-1369
Authors:
Yamane, K
Ihn, H
Asano, Y
Yazawa, N
Kubo, M
Kikuchi, K
Soma, Y
Tamaki, K
Citation: K. Yamane et al., Clinical and laboratory features of scleroderma patients with pulmonary hypertension, RHEUMATOLOG, 39(11), 2000, pp. 1269-1271
Authors:
Fujiwara, K
Tanaka, S
Ohtsuka, M
Nakaya, K
Maezumi, S
Yazawa, N
Hong, CX
Chida, T
Enomoto, H
Citation: K. Fujiwara et al., Investigation on behavior of bacteria in reservoir for microbial enhanced oil recovery, SEKIYU GAKK, 43(4), 2000, pp. 274-285
Citation: N. Yazawa et K. Tamaki, High prevalence of Helicobacter pylori type I virulent strains in patientswith systemic sclerosis - Drs. Yazawa, et al reply, J RHEUMATOL, 27(6), 2000, pp. 1569-1569
Authors:
Yamane, K
Ihn, H
Kubo, M
Yazawa, N
Kikuchi, K
Soma, Y
Tamaki, K
Citation: K. Yamane et al., Serum levels of KL-6 as a useful marker for evaluating pulmonary fibrosis in patients with systemic sclerosis, J RHEUMATOL, 27(4), 2000, pp. 930-934
Authors:
Ihn, H
Yazawa, N
Kubo, M
Yamane, K
Sato, S
Fujimoto, M
Kikuchi, K
Soma, Y
Tamaki, K
Citation: H. Ihn et al., Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease, J RHEUMATOL, 27(3), 2000, pp. 698-702
Authors:
Yamane, K
Ihn, H
Kubo, M
Yazawa, N
Kikuchi, K
Soma, Y
Tamaki, K
Citation: K. Yamane et al., Increased serum levels of soluble vascular cell adhesion molecule 1 and E-selectin in patients with localized scleroderma, J AM ACAD D, 42(1), 2000, pp. 64-69
Authors:
Yazawa, N
Kikuchi, K
Ihn, H
Fujimoto, M
Kubo, M
Tamaki, T
Tamaki, K
Citation: N. Yazawa et al., Serum levels of tissue inhibitor of metalloproteinases 2 in patients with systemic sclerosis, J AM ACAD D, 42(1), 2000, pp. 70-75
Authors:
Ihn, H
Sato, S
Fujimoto, M
Igarashi, A
Yazawa, N
Kubo, M
Kikuchi, K
Takehara, K
Tamaki, K
Citation: H. Ihn et al., Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis, CLIN EXP IM, 119(1), 2000, pp. 203-209
Authors:
Kubo, M
Ihn, H
Yamane, K
Yazawa, N
Kikuchi, K
Soma, Y
Tamaki, K
Citation: M. Kubo et al., Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositis, BR J DERM, 143(2), 2000, pp. 392-398
Authors:
Kubo, M
Ihn, H
Yazawa, N
Sato, S
Kikuchi, K
Tamaki, K
Citation: M. Kubo et al., Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis/dermatomyositis, J INVES DER, 112(5), 1999, pp. 711-715
Authors:
Ihn, H
Yamane, K
Yazawa, N
Kubo, M
Fujimoto, M
Sato, S
Kikuchi, K
Tamaki, K
Citation: H. Ihn et al., Distribution and antigen specificity of anti-U1RNP antibodies in patients with systemic sclerosis, CLIN EXP IM, 117(2), 1999, pp. 383-387